Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ptc therapeutics up big p/m after CHMP Recommends Renewal of Translarna'sâ„¢ Marketing Authorization
http://www.streetinsider.com/dr/news.php?id=12235916
U.S. Food and Drug Administration Approves Gilead’s Vemlidy® (Tenofovir Alafenamide) for the Treatment of Chronic Hepatitis B Virus Infection
http://www.businesswire.com/news/home/20161110006250/en/U.S.-Food-Drug-Administration-Approves-Gilead%E2%80%99s-Vemlidy%C2%AE
Earnings premarket Monday nov 7. Ariad
ARIAD Announces Publication of the Preclinical Profile of Brigatinib in the Journal Clinical Cancer Research
Preclinical data demonstrates activity against all tested ALK mutants
http://investor.ariad.com/phoenix.zhtml?c=118422&p=irol-newsArticle&ID=2215955
Just wait. You know another bio takeout is imminent While the next huge acquisition may not be our ariadne (maybe, right?) it'll resurface all of the optimistic chatter. All the tv personalities chime in on the sector. Yada yada Sure political risk is present with HC leading and prop 61. Even if prop 61 passes, biotechs will just adjust VA contract pricing
Yes. They announced that late tonight. I think they have earnings in the am too.
So what is your home language? Thoughtful answer. Thanks for chiming in bio_
Ariad is not profitable but the pressure is on the concept of recouping the R&D investment. They may as well fight every single American company. Look at Apple. Designed in sunny California then they state assembled in China. The phone I'm using right now retails for over $600 USD. Even more in Europe. You can bet your daddy's dollar iPhones assembled at Foxconn aren't even $100 to do. Why the gap between cost and retail. You got it. The American way of delivering shareholder value and making expensive regulations and R&D worth the investment Maybe AF should move to Scandanavia. See ya
But they pick on ariad.
Agreed. He wrote the street article based on his absolute personal hatred of ariad for reasons we don't know. He even has called ariad investors unintelligent and morons repeatedly. What a jerk. Or as we say in Pittsburgh. What a jaggof
AF is the moron cuz he insults heaps of people then tweets. He guys I'll be at this bar tonight. Come say hi. Some psycho is gonna show up and assault that guy. We are living in crazy times and I'm glad that I don't piss off people and remain unknown today.
Just saw the movie money monster with George Clooney. Interesting and hopefully that sort of thing never happens. However in this instant news impact age things are getting wild
Well done lax. Hopefully it doesn't get lost amongst his squad of staffers trying to one up each other
They have excellent sales per square foot for the sector. Recently corrected the "labor issues" that were weighing their payroll and benefits. They need a extremely strong sales season. Which we are in really through the end of spring. If they nail the thanksgiving stuff they should weather this.
While your at it ask him how many hard working Americans own three luxury homes like he now does
Wfm. Hepatitis in Detroit. No. that doesn't sound malicious at all
There's no grounds for liability in2das case. Unless this whole time he has been a board member undercover. That would be an interesting twist
Agreed.
He should be busy furnishing his third home on the luxurious shores of lake Champlain islands that he just scooped up being the blue collar guy he wanted laid off blue collars to believe in the campaign trail. I mean the average joe owns three homes right?
Hahaha. That was funny.
We will certainly here a company response after today.
Agreed.
Still scratching my head why the "crew" decided to use ariad as the company to attack due to price increases. AF continues to tweet about his article. Kinda feel like he still needs the world to confirm that he started it. Lol. But price increases are basically a reality with EVERY biotech company. Even companies that are orders of magnitude larger in market cap and cash on hand than little ariad. Companies that didn't have their one approved drug pulled from the market. Companies with huge pipelines. It's obvious that he is personally affected by ariad gotta vendetta. Maybe HB dissed him back in the day. Lol.
Isn't it sort of a given that ariad who is trying to re-emerge from the crash with wounds would need to increase somewhere and at sometime? The company was almost knocked out of commission. AF acts like iclusig is in every classroom across America. The greediest of the greedy.
But using ariad is weak IMO. 36% increase is the outlier? You gotta be kidding me. We could list dozens of better biotech examples to criticize under that argument. For drugs that are more widely used to! With larger price increases!
Just weird. Just weird for sure the games that are played by "the crew"
Nice reminder Barry. Regardless of twitter drama we are certainly in exciting times with ariad science.
Glta
That last part of your bit there I'm in agreement. The press talked all about ariad yesterday This is exactly how I heard of ariad but during the iclusig crash when it was lurking in the $2-3's. The attention got me researching the company My own DD lead me to take a position Just sharing my own experience that bad news for a company can actually be good news in terms of new investor recruitment.
Where I respectfully disagree with you is your stance on Denner. While I agree is isn't the savior of ariad. He deserves a little credit with some of the evolution since the crash. Let's face it the company could have closed shop back then. A lower chance of that but still a chance IMO. Also Denner told CNBC' tirrell directly that he entertains a sale of ariad. That he recommends ariad. That he is patient and to look at ariad going alone. He cleaned the useless top management and prepped for brig He has done just that. Shown patience. If baxalta made that offer it was smartly rejected.
All IMO
It is funny that Cramer says good and a stock tanks. Look at his 'beloved' Bristol maaaarrrs
Bernie sanders just tweeted about corporate greed using aria as example based on AF article
This mornings wsj has a cover story in amazons plan to build brick and mortar grocery stores. I'm trying to wrap my head around that being a winner. However there's a neat chart from cowen in the article about grocery market share. Wfm captures just 1.7% while the list topper Walmart captures 17.3%. Your bullish thesis will pan out if wfm can ascend this list for sure I'll tweet you the pic as ihub is acting up again
It's all about oncology/immunology with future funding interests across the board imo. It's the Silicon Valley in biotech
I agree. No traction. That why the article seems to be shrugged off my the masses.
ARIAD Presents Updated Long-Term Follow-up Results from the Phase 1/2 Trial on Investigational Drug Brigatinib at 2016 ESMO Meeting
http://www.businesswire.com/news/home/20161010005510/en/
Thanks for your response. All valid points dew. I'll respond when I get a chance.
Kroger? They are huge. The us govt barely allowed wfm to buy Lil wild oats a few years back. They'd freak over that merger for sure
I love wfm but where are the differentiators anymore? Even craptacular Aldi is making the wfm-style natural standard pledge. And Walmart sells kombucha. Walmart?? I can't believe it. Walmart even sells the same mangos (champagne) that wfm used to exclusively distribute and sells them for .50 each every day vs wfm 4/$5 when on sale. The mangos are incredible and from the same farms in Chiapas Mexico. Now Walmart sells them for .50. Why would you buy the SAME Mango for 1.25 on sale only from wfm? Wfm sells them for $1.50 each off sale. My point is that competitors find what is unique about wfm. Rob the differentiator
Wfm could squeak out that extra 1-2% margin markup cuz they had items that no conventional grocer cared about except the co-op world. Like kombucha. Cold-pressed EVOO Expanded vegan/veg offerings, fancy cheese dept, Scottish sourced salmon and extremely fresh seafoods and dry-aged meats, great bulk foods, fresh cut fruit case, unbleached/unbromated flour breads, all natural body care (incredible margin here) the list goes on. But everyone does this stuff now!
Whole Foods is excellent with retail and merchandizing standards. But grocers have copied all of their moves. In western pa and oh giant eagle has made bank on simply building wfm-looking stores named market district. These beast mode grocery stores have all the things wfm started. Like the wood fired grills. Great seafood and prep foods. Organics, performance kitchens, community outreach, yada yada Everyone sells the fage yogurt now for instance. Wfm doesn't have exclusive deals that are significant standouts. For instance they used to be the only retailer that exclusively started with extremely aged parmigiana reggiano wheels as a store standard. Competitors do the same now.
Wfm is great but they lost the edge cuz you can't copyright these things. Trader Joe's goes wherever they open and erodes their prep food and bulk opportunities. And regional grocers all over the country go into the stores and price match and copycat everything.
When they announced the 365 chain stores I didn't like it. To me it marked an act of desperation from a old tired management team. The innovator was now the copycat. Let's do what aldi and Trader Joe's is doing. I don't like that implication one bit
Also team member benefits are weaker now then 10 years ago where wfm could do no wrong. I am really worried about union penetration into the stores with challenged morale after the layoffs and for some questionable job security.
I just see the regional management across the wfm regions scrambling to find the differentials. And they aren't as visible as a decade ago leaving me rather neutral about the company's growth.
Opening new stores are outrageously expensive as well as operating their regional headquarters
Maybe wfm should merge with unfi so they could stick it to competitors who rely on unfi deliveries for inventory
I really hope wfm breaks out. Love shopping there but it acts way more like a conventional operation than the conscious capitalist of Mackey's dream
Also I agree he is a good reporter and writer however the drama addiction is def an odd part of his routine
Yes I totally agree dew. The price increase didn't strike me as a sector standout. He just hates ariad. Maybe it's Harvey. He's gotta give the new management a chance as he's been negative for years on ariad
Where was his positive thoughts say around asco or other good ariad announcements? Crickets from the AF camp
He can't just report news say like Meg tirrell does. He is addicted to the drama fueled social media reporting that is Twitter
I'm not necessarily saying I hate AF but he certainly hates ariad. Been bashin for years. Deciding to highlight ariad over a 8% increase which I find on par not an outlier is proof. He could have written about any biotech company. 8% come on Adam
CelSci (CVM).
FDA places multi-kine study on clinical hold.
http://finance.yahoo.com/news/cel-sci-reports-clinical-hold-030300826.html
This is a lot to 'digest' TC!
Nice one! As far as 32788 is concerned I'd love to be at the negotiations table where a bidder gets the opportunity to see what ariad has really got for sale. (We the public aren't invited) Sounds like clacksons team is very excited about the new molecule. Seeing how these companies put together a buyout offer once briefed on Ariad's classified info has got to be a neat thing to watch.
That's a great question. I think it's you have to hold shares through to a determined date based on the deal
I posed it to Dew on the biotech values board. Here's his answer.
"Yes. The CVR contains some elements where the triggering events won't happen for several years (if they happen at all); however, TBRA shareholders will capture the designated CVR value provided they hold the stock on the record date for the deal closing.
The TBRA CVR is apparently not tradable insofar as AGN's SEC filings are silent on this question"
Thanks Dew! So my assumption that cvr value would be determined by deal end isn't always correct. As in this case shareholders as of that predetermined date can collect on the cvr right years after the acquisition. Neat incentive
Awesome. Thanks!
Dew. That CVR worth potentially $49+. Do you know if they work out that right value prior to the deal being finished? It's contingent on events yet to unfold How does that work in relation to current shareholders wondering how much they will actually end up per share ?
Can the acquisition actually finish before the cvr value can be determined?
It's a confusing category for sure and since the present value of the CVRs can fluctuate depending on the forthcoming events/study results it's difficult to nail a present value of a cvr.
But my understanding is since the acquirer is assuming a greater risk in the the deal since these cvr's are based on events yet to unfold, the acquiring company transfers that risk onto the current shareholders of the acquired company thus allowing the buyer to offer a more attractive takeout price range to the shareholders of the company to be sold.
So therefore yes the CVRs only apply to folks who own shares in the company being bought. CVRs usually have a life span And I assume the final price of these CVRs are worked out by the time the deal is finished and the timeline for the contingent details occur within that timeframe
I'm certainly trying to learn more about these incentives and am wondering how Denner would articulate them during a deal negotiation as ariad imo has plenty of cvr-worthy instances-Japan approval and increased sales thresholds being a good start.
The allergan Tobira deal offered a fasinating detail to acquisitions that we rarely discuss Here below is a direct quote from allergens pr
"Allergan will acquire Tobira for an upfront payment of $28.35 per share, in cash, and up to $49.84 per share in Contingent Value Rights (CVRs) that may be payable based on the successful completion of certain development, regulatory and commercial milestones".
These CVRs aren't new but rarely discussed But the premium price of 28-49 bucks is a significant difference
Applying that to Ariad I'll let you use your imagination as pertaining to a takeout offer proposal